AIDS Demans Kompleksi Olgu Sunumu

  • Suat Kamışlı İNÖNÜ ÜNİVERSİTESİ TIP FAKÜLTESİ NÖROLOJİ ABD. MALATYA
  • Özden Kamışlı
  • Sinan Gönüllü
  • Sibel Çıplak

Abstract

Edinsel immün yetmezlik sendromu, demans, parkinsonizm

References

Centers for Disease Control and Prevention (CDC). Trends in HIV/AIDS diagnoses among men who have sex with men 33States, 2001-2006. MMWR Morb Mortal Wkly Rep 2008; 57:681–6.

Koralnik IJ. Neurologic diseases caused by human immuno defici ency virus-1 and opportunistic infections. In: Mandell GL, Bennett JE,Dolin R, (eds.). Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005; 1583-601.

Góngora-Rivera F, Santos-Zambrano J, Moreno-Andra de T, Calza daLópez P, Soto-Hernández JL. The clinical spectrum of neurological manifestations in AIDS patients inMexico. Arch Med Res 2000;31:393-8.

Budka H. Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis. Acta Neuropathol Berl 1989; 77: 225–36.

Portegies P, Enting R H, de Gans J, Algra PR, Derix MMA, Lange JMA, et al. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. AIDS 1993; 7:669–75.

Simpson DM, Berger JR. Neurologic manifestations of HIV infection. Med Clin North Am 1996; 80:1363-94.

Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL. Rapidly Progressive Dementia. Ann Neurol 2008; 64:97-108.

Roberson ED, Hesse JH, Rose KD, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology 2005;65:719–25.

Rascovsky K, Salmon DP, Lipton AM, et al. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology 2005;65:397–403.

Cercy SP, Bylsma FW. Lewy bodies and progressive dementia: a critical review and metaanalysis. JInt Neuropsychol Soc 1997;3:179–94.

Holloway RG, Kieburtz JKD. In: Mandell GL, Bennett JE, Dolin R, eds. Neurologic manifestations of HIV infection. Mandell, Douglasand Bennett’s Principles and Practice of Infectious Diseases. 4th ed. New York: Churchil Living stone; 2000: 1432-9.

Teja VD, Talasila SR, Vemu L. Neurologic manifestations of HIV infection: an Indian hospital based study. AIDS Read 2005;15:139-43.

Yan YF,Wang ZY,Pu SS, Wen HL,Huang T,Song YY et al. HIV-1B gp120 genes from one patient with AIDS dementia complex can affect the secretion of tumor necrosis factor and interleukin 1β in glial cells. Chin Med J(Engl) 2011;124:4217-22.

Price RW. Understanding the AIDS dementia complex (ADC). The challenge of HIV and its effects on the central nervous system. Res Publ Assoc Res Nerv Ment Dis 1994; 72:1–45.

Epstein LG, Gendelman HE. Human immunodeficiency virus type 1infection of the nervous system: Pathogenetic mechanisms. Ann Neurol 1993;33: 429–36.

Burger DM, Kraaijeveld CL, Meenhorst PL, Mulder JW, Koks CH, Bult A et al. Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV. AIDS 1993; 7:1581–7.

Lewis PR. Merritt’s Neurology Tenth Edition. Lippincott Williams &Wilkins, Philadelphia, 2000: 163–7.

Powers A. Diabetes mellitus. In: Kasper DL, Fauci AS, Longo D, et al., editors. Harrison's principles of internal medicine. 16th ed. New York: McGraw-Hill; 2005:2169–70.

Blank LJ, Polydefkis MJ, Moore RD,Gebo KA. Herpes zoster among persons living with HIV in the current antiretroviral therapy era. J Acquir Immune Defic Syndr 2012; 61:203-7.

Published
2013-06-28